Literature DB >> 15971432

Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronate.

P Coppo1, S Lassoued, T Billey, K Lassoued.   

Abstract

We describe the case of a 70-year-old man with unicentric grade 1 epitheloid hemangioendothelioma (EH) of the bone that favourably responded to intravenous pamidronate as a single agent. After 6 years of follow-up, the patient was in complete remisssion. We suggest that use of bisphosphonates should be considered in the treatment of osteolytic EH.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15971432

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.

Authors:  Augustine Lau; Steve Malangone; Myke Green; Ambuga Badari; Kathryn Clarke; Emad Elquza
Journal:  Ther Adv Med Oncol       Date:  2015-07       Impact factor: 8.168

2.  A trimodality approach in the management of metastatic low-grade epithelioid hemangioendothelioma of the bone.

Authors:  Abhijit Saste; Diego Felipe Cabrera Fernandez; Rohit Gulati; Steven Gamalski
Journal:  BMJ Case Rep       Date:  2015-07-16

Review 3.  Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature.

Authors:  María Lorena Brance; Nicolás M Cóccaro; Pablo Roitman; Alejandro Castiglioni; Florencia Agostinis; Mariel Spense; Bárbara Scheitlin; Nicholas Rene; Lucas R Brun
Journal:  Arch Osteoporos       Date:  2022-02-01       Impact factor: 2.617

4.  Minimally invasive treatment of a painful osteolytic lumbar lesion secondary to epithelioid hemangioendothelioma.

Authors:  Arjun S Sebastian; Marcus J Adair; Jonathan M Morris; Mustafa H Khan; Carola A S Arndt; Ahmad Nassr
Journal:  Global Spine J       Date:  2014-08-05

5.  Bisphosphonates as a therapeutic choice for multifocal epithelioid hemangioma of bone: A case report.

Authors:  Lizhi Tang; Guangwen Chen; Qin Wang; Jobin John; Chunyan Lu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.